The institutions that make this research possible.
Beyond funding and consortia, our studies depend on the clinical, computational, and academic infrastructure of a few key institutions.
Where the clinical and computational work happens.
Massachusetts General Hospital
Dr. Leong practices in the Divisions of Endocrinology and General Internal Medicine at MGH, and the Diabetes Research Center is where every human study — TARGET, CGM-A1c Genetics, COVID, and PROGRESS — is actually run.
See Our Studies →
Mass General Brigham
MGH’s parent health system, whose electronic health records and genotyped biobank make recall-by-genotype recruitment possible — identifying study participants at the extremes of genetic risk directly from real clinical data.
See Our Collaborations →
Harvard Medical School
Dr. Leong is Assistant Professor of Medicine at Harvard Medical School, the academic home for the team’s teaching, mentorship, and academic appointments.
Broad Institute of MIT and Harvard
Dr. Leong is an Associate Member of the Broad Institute, home to the computational genomics infrastructure and several collaborators — including Dr. Josep Mercader’s group — behind this team’s genetic discovery work.
Meet Our Collaborators →
Center for Genomic Medicine
MGH’s dedicated center for genomic research, home to the Florez Lab and the broader genomic medicine infrastructure that supports this team’s genotyping, sequencing, and genetic association work across all four active studies.